Nantes Bariatric Surgery Cohort
Condition(s) studied
Investigational drug(s) / intervention(s)
Nantes bariatric surgery cohort: The participants will be individuals living with obesity undergoing bariatric surgery
Study summary
While current research suggests that inflammation of adipose tissue in obesity is linked to accelerated aging, it has yet to be determined in humans how this could enhance preventative and personalized medicine for obese individuals. The NBC study aims to investigate :
1. Whether bariatric surgery is associated with changes in biological age
2. If bariatric surgery alters adipocyte dysfunction, the microbiota and biological rhythms
3. Whether changes in adipocyte dysfunction, microbiota and biological rhythms are linked to changes in biological age.
To achieve this, establishing a biocollection before, during and after bariatric surgery will be crucial in addressing these questions
Eligibility
Primary outcome measure(s)
- Observe how biological age evolves between pre-bariatric surgery and 1 year after bariatric surgery — 1 year
Biological age will be estimated by measuring phenotypic age. The phenotypic age will be determined from the following variable: albumin, creatinine, fasting glucose, CRP, lymphocyte count, red cell size, alkaline phosphates, leukocyte count.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Nantes University Hospital | Nantes | Loire-Atlantique | Recruiting |
More Nantes University Hospital trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06625762 on ClinicalTrials.gov ↗ ← All trials in France